Abstract: Although the significance of focally enhanced gastritis (FEG) as a marker of Crohn disease (CD) in adults has been contested, several studies suggest that it may be more specific of CD in pediatric patients. This study describes the detailed histologic features of FEG in pediatric inflammatory bowel disease (IBD) and clarifies its association with CD. A series of 119 consecutive newly diagnosed IBD patients (62 CD cases, 57 ulcerative colitis [UC] cases) with upper and lower gastrointestinal biopsies were evaluated. The histology of the gastric biopsies was reviewed blinded to final diagnoses and compared with age-matched healthy controls (n = 66). FEG was present in 43% of IBD patients (CD 55% vs. UC 30%, P = 0.0092) and in 5% of controls. Among CD patients, FEG was more common in younger patients (73% in children aged 10 y and below, 43% in children above 10 y of age, P = 0.0358), with the peak in the 5-to 10-year age group (80%). The total number of glands involved in each FEG focus was higher in UC (6.4 ± 5.1 glands) than in CD (4.0 ± 3.0 glands, P = 0.0409). Amongst the CD cohort, patients with FEG were more likely than those without FEG to have active ileitis (79% vs. 40%, P = 0.0128) and granulomas elsewhere in the gastrointestinal tract (82% vs. 43%, P = 0.0016). There was no correlation between FEG and other gastrointestinal findings of UC. We demonstrate that differences in FEG seen in pediatric CD and UC relate to not only their frequencies but also the morphology and relationship with other gastrointestinal lesions. Further, FEG is associated with disease activity and the presence of granulomas in pediatric CD.
T he appropriate classification of idiopathic inflammatory bowel disease (IBD) as either Crohn disease (CD) or ulcerative colitis (UC) is important because of their differences in natural history, treatment, and prognosis. However, establishing a definitive diagnosis can be challenging because of the overlapping features between these 2 disorders and the possibility of CD-like features in cases of naive UC, such as discontinuous disease, rectal sparing, and ileal inflammation, particularly in pediatric patients. [1] [2] [3] [4] [5] [6] In many cases, the key to histologic differentiation between CD and UC is largely limited to the identification of granuloma regardless of the segment of involvement. Consequently, in the pediatric setting esophagogastroduodenoscopy is routinely performed during the initial evaluation for IBD, as up to 20% of children with CD have granulomas limited to the upper gastrointestinal tract. [7] [8] [9] Focally enhanced gastritis (FEG) is an inflammatory lesion often found in CD and involves discrete inflammatory foci containing lymphocytes, histiocytes, and granulocytes. FEG has been suggested as a specific marker of CD, detected with a prevalence ranging from 43% to 76%. [10] [11] [12] [13] However, the specificity of FEG for CD has been challenged, as several studies have demonstrated that FEG is found in 12% to 24% of UC patients and 2% to 19% of non-IBD patients. 10, [13] [14] [15] In addition, a study reported a lower prevalence of 10.5% of FEG in adult-onset CD patients with a positive predictive value of only 5.9%. 16 Nevertheless, FEG has been touted as more specific for IBD in the pediatric population. Sharif and colleagues demonstrated that FEG was present in 65% of CD and 21% of UC cases but only 2% of non-IBD pediatric patients, and similar findings were confirmed by 2 recent studies. 14, 15, 17 Altogether, the predictive value of FEG during an evaluation for IBD is unclear, and a thorough histologic description of FEG seen in children with IBD is lacking.
The goals of this study were to further determine the diagnostic significance of FEG in pediatric patients and to better characterize the histologic features of FEG. First, a retrospective histologic review of gastric biopsies from pediatric patients who presented with new-onset IBD was performed to establish the prevalence of FEG. Second, the clinicopathologic characteristics of FEG were examined with particular attention to differences between CD and UC. Finally, a detailed review of concurrent esophageal, duodenal, ileal, and colonic biopsies was performed to assess for correlations between the presence of FEG and other mucosal gastrointestinal lesions.
MATERIALS AND METHODS

Selection of Patient Cohort
Consecutive patients with IBD who received care in the pediatric gastroenterology clinic of MassGeneral Hospital for Children between March 2010 and March 2012 were identified by electronic medical record review. The original biopsies from those with a confirmed final diagnosis of CD and UC who underwent both upper and lower endoscopic evaluation (with biopsy) at the time of their IBD diagnosis (and were naive to treatment) were reviewed. The ultimate diagnosis and classification of IBD was established on the basis of the correlation of endoscopic, pathologic, and imaging findings, as well as the clinical course. Patients who were diagnosed at another institution or who did not have upper endoscopy before the establishment of the diagnosis (and initiation of therapy) were excluded. Patients were accrued into age groups (on the basis of their age at the time of initial endoscopic evaluation) defined a priori: 0 to 5 years of age, 6 to 10 years of age, 11 to 15 years of age, 16 to 17 years of age, and 18 to 20 years of age. The endoscopy report was examined for macroscopic gastric lesions (ie, gastric erythema, aphthoid lesions). In addition, the location and extent of the lower gastrointestinal disease was classified according to the Paris classification. 18 The average duration of follow-up for IBD patients was 3.5 ± 2.4 years. The control group was age matched to the study group. This group was composed of randomly selected patients who underwent upper endoscopic examination with biopsy without significant gross findings during the same period (March 2010 to March 2012). This control group consisted of patients with nonspecific upper gastrointestinal symptoms (eg, epigastric pain, bloating, nausea) without lower gastrointestinal symptoms (n = 43) and those with both upper gastrointestinal symptoms and mild lower gastrointestinal symptoms who had a concomitant colonoscopy without pathologic findings. Controls were followed up for an average of 8.5 ± 0.7 months after endoscopy without development of further symptoms. For both IBD and control groups, the institutional standard pediatric biopsy protocol was applied-that is, 2 biopsies were taken per site using standard adult-size biopsy forceps.
This project was approved by the Institutional Review Board of the Massachusetts General Hospital.
Histologic Assessment
All serial sections of each biopsy specimen were examined by 1 gastrointestinal pathologist (T.U.) who was blinded to the patient's clinical condition and the final diagnosis. Between 8 and 10 hematoxylin and eosinstained serial sections typically were available for each case. Additional deeper sections were often available for review in cases with equivocal findings, such as the presence of possible granuloma or FEG.
Gastric Biopsies
Each gastric biopsy was evaluated for the presence of FEG. FEG was defined as the presence of 1 or more foci of pit or glandular inflammation with a relatively normal background mucosa. 12 All cases with focal inflammatory lesions were rereviewed by 2 pathologists (T.U. and G.Y.L.) together using a multiheaded microscope to render a consensus diagnosis. For each gastric biopsy, the number of foci of FEG, the total number of glands or foveolae involved by FEG, and the type of inflammatory cells composing the FEG focus (eg, lymphocytes, plasmacytes, neutrophils, eosinophils, or histiocytes) were recorded. Finally, the presence of a granulomatous reaction, defined as aggregations of epithelioid granuloma or multinucleated giant cells (sometimes observed adjacent to foci of FEG), was also assessed. A diagnosis of "granulomatous gastritis" was applied for cases showing epithelioid granulomas with or without multinucleated giant cells unrelated to inflamed pit/gland. Helicobacter pylori infection was excluded on the basis of morphology. In addition, negative immunostaining for H. pylori or using thiazine stain was observed in 73% of biopsies with any type of gastritis.
Extragastric Gastrointestinal Biopsies
Histologic features of concurrent esophageal, duodenal, ileal, and colorectal biopsies were also evaluated and analyzed in association with FEG. The recorded diagnoses are listed in Table 1 .
Statistical Analysis
Continuous variables were compared using the Student t test, and categorical variables were compared using the Fisher exact test or w 2 test (Excel Statistics; SSRI, Tokyo, Japan). Differences were considered to be significant if the 2-tailed P-value was <0.05.
RESULTS
Study Group
A total of 119 consecutive patients were accrued into the a priori-defined age groups (0 to 5 y of age [ 
Prevalence of FEG in IBD Patients and Controls
FEG was detected in 43% of the IBD patients (51/ 119) and in 5% of control children (3/66) (P < 0.0001). FEG was also more frequently observed in patients with CD (55%, 34/62) than those with UC (30%, 17/57, P = 0.0092) and controls (5%, 3/66, P < 0.0001).
Among the patients with CD, the prevalence of FEG was higher in the younger age groups (73% in children aged 10 y and below, 43% in children above 10 y of age, P = 0.0358), with the peak in the 6-to 10-year age group (80%). There was no significant relationship between the frequency of FEG and the age of the patients with UC or the control group. were more commonly seen in IBD patients with FEG than in those without FEG (49.0% vs. 26.5%, P = 0.011). Aphthoid lesions were also more common in IBD patients with FEG than in those without FEG (21.6% vs. 7.4%, P = 0.024). 
Endoscopic Appearance and FEG
Disease Location and FEG
Histologic Pattern of FEG in CD and UC
The number of FEG foci ranged from 1 to 5 (mean: 2.2) in each biopsy specimen (Figs 1, 2) . Each FEG lesion involved from 1 to 12 pits/gland and mostly up to 3 pits/gland (87%). These characteristics did not differ between CD and UC patients. However, the total number of glands involved as part of a focus of FEG was higher in patients with UC (6.4 ± 5.1) compared with those with CD (4.0 ± 3.0, P = 0.0409). The characteristic features of FEG in patients with CD and UC are summarized in Table 3 . All FEG lesions contained lymphohistiocytic infiltrates. In addition, 33% of FEG lesions had varying degrees of granulocytes (neutrophils in 26% and eosinophils in 12% of the cases), and 33% were accompanied by a granulomatous reaction (Fig. 3) . Granulocytic infiltrates were less frequently observed in FEG lesions from CD patients (26%) compared with those found in UC patients (47%), whereas ill-formed histiocytic aggregate reactions were more frequently present adjacent to FEG in CD (41%) than in UC patients (18%); however, these differences did not reach statistical significance (Table 3 ). The granulomatous reaction adjacent to the FEG focus was usually composed of a small aggregate of epithelioid histiocytes or even included multinucleated giant cells. However, prominent, middle-sized epithelioid granulomas were also observed in 2 cases. Table 4 shows a summary of the diagnoses encountered in all biopsies.
Characteristics of Gastrointestinal Biopsies and Their Association With FEG
The detection of esophagitis was higher in patients with CD than UC (26% vs. 11%, P = 0.0360) and those of the control group (26% vs. 11%, P = 0.0370). Granulomatous esophagitis was exclusively found in CD patients (11%). There was no significant difference among the 3 groups of patients with regard to the other esophageal findings.
In the stomach, the presence of gastritis (all variants combined) was more common in patients with CD (73%) than UC (44%, P = 0.0017) and in the children of the control group (9%, P < 0.0001). Granulomatous gastritis was present in 15% of the patients with CD. However, the prevalence of the other subtypes (chronic active gastritis and chronic inactive gastritis) did not differ among the 3 groups.
Duodenitis was more frequent in the CD group (23%) and the UC group (28%) than in the control group (5%, P = 0.0034 and 0.0003, respectively). Granulomatous duodenitis was present in 6% of the patients with CD. Similarly, chronic active duodenitis with foveolar metaplasia (consistent with peptic injury) was observed in patients with CD (6%) and UC (5%).
The frequency of active ileitis was significantly higher in patients with CD (58%) than in those with UC (11%, P < 0.0001). Active ileitis in UC patients was always patchy and mild compared with the ileitis seen in 42% of CD patients. Ileitis in the CD cohort was moderate to severe and was often accompanied by erosion or ulceration. Granulomatous ileitis was detected in 22% of CD patients. In colonic biopsies, active inflammation was observed in at least 1 biopsy in 96% of the UC patients and 74% of those with CD (P = 0.0007). Granulomatous colitis was present in 58% of the patients with CD.
Correlation of FEG With Active Inflammation Elsewhere in the Gastrointestinal Tract
Lymphocytic esophagitis was included in this analysis because it has been suggested as a manifestation of pediatric CD. 19, 20 Lymphocytic esophagitis, active duodenitis, and active ileitis were more frequently observed in CD patients with FEG compared with those without, although the former 2 did not reach significance. There was also no difference between the presence of FEG and the presence of active colitis. The results are presented in Table 5 . In UC patients, there was no correlation between the presence of FEG and other mucosal findings, including the activity of colitis.
Correlation of FEG With the Presence of Granulomas in CD
Epithelioid granulomas were more frequently observed in CD patients with FEG than in those without FEG, in both upper and lower gastrointestinal biopsies (Table 5) . Granulomas in CD patients with and without FEG were present in esophageal (18% vs. 4%, P = 0.1160), gastric (24% vs. 4%, P = 0.0332), duodenal (9% vs. 4%, P = 0.6199), terminal ileal (36% vs. 10%, P = 0.0445), and colonic (74% vs. 36%, P = 0.0044) biopsies. Overall, 82% CD patients with FEG had at least 1 granuloma detected in their gastrointestinal biopsies, whereas the frequency was only 43% in those without FEG (P = 0.0016).
Correlation of FEG With the Presence of Lower Gastrointestinal Symptoms
Given the concern for overlooking a diagnosis of IBD in patients with FEG, the frequency of 2 common lower gastrointestinal symptoms, rectal bleeding and diarrhea, was assessed in the IBD cohort. Rectal bleeding and diarrhea was present in 90.2% (46/51) of IBD patients with FEG compared with 91.2% (62/68, P = 0.86) of patients with IBD without FEG.
DISCUSSION
The recognition of FEG as a gastric manifestation of IBD was first reported in 1997 by Oberhuber et al. 12 The prevalence of FEG in pediatric IBD patients is 54% to 69% in CD and 16% to 24% in UC, whereas it is present in 2% to 7% of non-IBD pediatric patients. 14, 15, 17, 21 Further, several studies have indicated a particularly high prognostic value in pediatric patients, as 61% to 76% of children with FEG are ultimately diagnosed with IBD. 17 However, although FEG is particularly common in children with CD, the presence of FEG does not reliably distinguish CD and UC in isolation. 17 Our study is the first to examine a cohort of children with newly diagnosed IBD for the occurrence of FEG.
This study is the first to comprehensively define the histologic differences in FEG between CD and UC patients. We demonstrated that compared with what is seen in UC patients, FEG in CD involved a lesser number of pits/glands in each gastric biopsy. Although a granulomatous reaction observed in association with FEG could be a manifestation of CD, it is not always easily distinguishable from a mucin-type granuloma developing secondary to a ruptured crypt, as described in the colon. [22] [23] [24] However, in practice, these subtle morphologic differences of FEG cannot always reliably differentiate between CD and UC.
We also show that FEG in our pediatric CD population was commonly associated with the presence of granuloma elsewhere in the gastrointestinal tract, as well as with active inflammation. Indeed, 82% of CD patients with FEG had granulomas in either upper or lower gastrointestinal biopsies, which were observed in only 43% of those without FEG. Perhaps more intriguing is that the detection of microscopically active ileitis was significantly more frequent in CD patients with FEG (79%) compared with those without FEG (40%, P = 0.0128), indicating that FEG may be a marker of disease activity along with the presence of granuloma in pediatric CD. In contrast, no significant correlation was noted between the presence of FEG and any clinicopathologic parameter in UC patients. This observation suggests that FEG in UC patients, in contrast to those with CD, is likely not directly related to the activity of the disease, although the significance of upper gastrointestinal lesions of UC remains unknown. 15, 25 Clearly, children with IBD have a much higher prevalence of FEG than non-IBD subjects. 14, 15 The identification of FEG in a pediatric patient with gastrointestinal symptoms raises the possible diagnosis of IBD, and, thus, it is interesting that a large retrospective study found no differences in the prevalence of FEG between the disease location of newly diagnosed IBD (by Paris classification) and advocated for thorough evaluation for CD with the detection of FEG. 21 Similarly, we also observed no association with the macroscopic disease location. However, our study did find a strong association between FEG and both ileal histologic activity and the presence of granulomas.
The absence of lower gastrointestinal biopsies from our control group could be construed as a limitation of our study. However, although a significant majority of patients with FEG and IBD had lower gastrointestinal symptoms (rectal bleeding or diarrhea), these symptoms were absent in the control group. Further, the associated histologic activity detected in the duodenum and esophagus of IBD patients was not noted in the control group, and, finally, at the time of patient selection, none of the patients of the control group had been retroactively diagnosed with IBD (with an average follow-up of 8.5 mo).
In summary, we confirmed that, although FEG is more typical of CD, it is also seen in a substantial number of children with UC. We also demonstrated that there are differences between FEG observed in CD and UC not only with regard to morphology but also the relationship with other mucosal abnormalities. Notably, FEG may be an indicator of disease activity and a marker for the presence of granulomas in pediatric CD. Thus, the detection of FEG in a pediatric patient with gastrointestinal symptoms but lacking any further evidence for histologic or endoscopic inflammation is unlikely to signal underlying CD.
